Pacific Biosciences Of Califor
PACB
$1.35+0.09 (+7.14%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 2.72 | 52Week Low | 0.91 |
| Beta | 2.13 | Current Ratio Annual | 7.48 |
| Current Ratio Quarterly | 6.68 | Gross Margin TTM | 19.49 |
| Market Cap | 276.62M | Net Profit Margin TTM | -431.71 |
| Operating Margin TTM | -438.10 | Price To Book | 3.02 |
| Price To Sales TTM | 1.82 | Quick Ratio Annual | 6.31 |
| Quick Ratio Quarterly | 5.64 | Return On Assets TTM | -51.78 |
| Return On Equity TTM | -170.40 | Return On Investment TTM | -56.90 |
| Revenue Growth3Y | 5.68 | Revenue Growth5Y | 11.12 |
| Revenue Growth Quarterly Yoy | -4.27 | Revenue Growth TTMYoy | -23.98 |
| Revenue Per Share TTM | 0.51 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 222 | 34 | 35 | 58 | 70 | 56 | 227.23M | $260.26M |
| Jun 30, 2025 | 84 | 11 | 18 | 22 | 25 | 21 | 63.73M | $78.68M |
| Change | 138(62%) | 23(68%) | 17(49%) | 36(62%) | 45(64%) | 35(63%) | 163.50M(72%) | $181.58M(70%) |